Articles |

Response to Symptom-Limited Exercise in Patients With the Hepatopulmonary Syndrome FREE TO VIEW

Scott K. Epstein; Marya D. Zilberberg; Cindy Jacoby; Ronald L. Ciubotaru; Linda M. Kaplan
Author and Funding Information

From the Pulmonary and Critical Care Division, Department of Medicine, Tupper Research Institute, and Cardiopulmonary Exercise Physiology Lab, New England Medical Center, Tufts University School of Medicine, Boston, MA.

Scott K. Epstein, MD, FCCP, Pulmonary and Critical Care Division, Box 369, New England Medical Center, 750 Washington St. Boston, MA 02166

1998 by the American College of Chest Physicians

Chest. 1998;114(3):736-741. doi:10.1378/chest.114.3.736
Text Size: A A A
Published online


Objective: To study the response to symptom-limited exercise in patients with the hepatopulmonary syndrome (HPS).

Design: The response to maximal cardiopulmonary exercise (CPX) was studied in 5 patients with HPS and compared with 10 case control (normoxemic, NC) cirrhotics (matched for age, gender, etiology and severity of liver disease, tobacco use, and β-blocker therapy) and 9 hypoxemic control cirrhotics (HC) without clinical evidence of HPS.

Setting: Cardiopulmonary exercise physiology laboratory in a tertiary care referral center.

Patients: Cirrhotics referred for CPX as part of their preliver transplantation evaluation.

Measurements: Standard pulmonary function tests and echocardiography were performed to assess resting pulmonary and cardiac function. Peak oxygen consumption (VO2), minute ventilation, arterial blood gases, and dead space (VD/VT) were detennined during symptom-limited maximal CPX.

Results: Resting spirometry and lung volumes were similar between HPS and NC subjects, while HC subjects had restrictive physiology. Differences existed in diffusing capacity corrected for hemoglobin and alveolar volume percent predicted (HPS, 45±2 vs NC, 68±3, p<0.05; vs HC, 70±4, p<0.05), PaO2 (HPS, 70±5 mm Hg; HC, 79±3 mm Hg, vs NC, 102±3 mm Hg, p<0.05) and alveolar-arterial (A-a) O2 gradient (HPS, 42±8 mm Hg vs HC, 27±2 mm Hg, p<0.05; vs NC, 6±2 mm Hg, p<0.05). During CPX, HPS patients achieved a lower peak VO2 percent predicted (HPS, 55±6 vs NC, 73±3, p<0.05; vs HC, 71±5, p<0.05) and VO2 at the ventilatory threshold as percent predicted peak VO2 (HPS, 36±2 vs NC, 55±4, p<0.05; vs HC 55 ±5, p<0.05). While no differences existed in heart rate and breathing reserve, HPS patients had significantly lower PaO2 (HPS, 50±5 mm Hg vs NC, 97±4 mm Hg, p<0.05; vs HC, 87±6 mm Hg, p<0.05), wider A-a O2 gradient (HPS, 73±5 mm Hg vs NC, 13±3 mm Hg, p<0.05; vs HC, 31±5 mm Hg, p<0.05) and higher VD/VT (HPS, 0.36±.03 vs NC, 0.18±.02, p<0.05; vs HC, 0.28±.02, p<0.05) at peak exercise. For HPS patients, VO2 was negatively correlated with VD/VT (r2=0.9) and positively correlated with PaO2 (r2=0.41) at peak exercise.

Conclusions: Patients with HPS demonstrate a severe reduction in aerobic capacity, beyond that found in cirrhotics without syndrome. The significant hypoxemia and elevated VD/VT at peak exercise suggest that an abnormal pulmonary circulation contributes to further exercise limitation in patients with HPS.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543